Delta G New therapies from understanding ageing

Delta G's business <Archive>

Delta G is a drug discovery company. We identify and apply cutting edge research to create new candidate drugs for major unmet medical need.

Our core expertise is in the biology of ageing, and how this can be understood to target the diseases of ageing with radical new therapies. We take a pragmatic approach to researching drugs for diseases where we can demonstrate success rapidly: in the lab., in proof of concept experiments, and in the clinic. Our short-term goal is to realise value from our knowledge base in cancer therapeutics. Our long-term vision is to make a major difference to human health and longevity.

Delta G intends to commercialise its research through partnerships on its preclinical programmes with industry. We are developing opportunities in cancer and Chronic Fatigue Syndrome (CFS), in research materials, diagnostics and therapeutics.

We welcome discussions with potential partners in any of these exciting opportunity areas.